CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC

1:25-cv-00075

Overview

Case Number 1:25-cv-00075
Filing Date 2025-01-17
Status Litigation filed
Court District Court, D. Delaware (ded)
Presiding Judge Jennifer L. Hall
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Azurity Pharmaceuticals, Inc.

Represented By

2 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Daniel Taylor

Smith, Katzenstein & Jenkins LLP

Tel: +1 (302) 504-1681

1000 West Street, Ste 1501

Slayback Pharma LLC

Represented By

2 Attorneys Listed

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Daniel Taylor

Smith, Katzenstein & Jenkins LLP

Tel: +1 (302) 504-1681

1000 West Street, Ste 1501

Plaintiff

Eagle Pharmaceuticals, Inc.

Represented By

3 Attorneys Listed

Maliheh Zare

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

405 N. King Street, Wilmington, DE 19801

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Jennifer L. Hall

Patents Involved

1 Patent

There is a single patent involved in this case.

Application Number Patent Number External Links
- US12138248

Docket Entries

COMPLAINT with Jury Demand against Slayback Pharma LLC (Filing fee $ 405, receipt number ADEDC-4593729) - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(scs) (Entered: 01/17/2025)

2025-01-17
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 01/17/2025)

2025-01-17
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,138,248. (scs) (Entered: 01/17/2025)

2025-01-17
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eagle Pharmaceuticals, Inc.. (scs) (Entered: 01/17/2025)

2025-01-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc